Aktuellt
SENASTE
Redeye initiates coverage of Sedana Medical, a medtech/pharma company challenging the standard of care for sedation in intensive care units. We see good prospects for it to ignite a paradigm shift in this industry, and we identify ample growth opportunities across all time horizons. The high operating leverage we expect bodes well for elevated, profitable growth in the short to medium term, which is not fairly reflected in the current share price.
LÄS MER
